Upper gum cancer
disease diseaseOn this page
Also known as cancer of gingiva of upper jawgingiva of upper jaw cancermalignant gingiva of upper jaw neoplasmmalignant neoplasm of gingiva of upper jawmalignant tumor of upper gingivamalignant tumor of upper gummalignant tumour of upper gingiva
Summary
Upper gum cancer (MONDO:0004615) is a cancer. A subtype of gingival cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | upper gum cancer |
| Mondo ID | MONDO:0004615 |
| DOID | DOID:8601 |
| SNOMED CT | 363383000 |
| UMLS | C0153365 |
| MedGen | 509265 |
| GARD | 0024076 |
| Anatomy (UBERON) | UBERON:0011601 |
| Is cancer (heuristic) | yes |
Also known as: cancer of gingiva of upper jaw · gingiva of upper jaw cancer · malignant gingiva of upper jaw neoplasm · malignant neoplasm of gingiva of upper jaw · malignant tumor of upper gingiva · malignant tumor of upper gum · malignant tumour of upper gingiva
Disease family
This is a subtype of gingival cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › musculoskeletal system cancer › gingival cancer › upper gum cancer
Related subtypes (1): lower gum cancer
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.